Sarcoid-like lesion is a frequent benign cause of lymphadenopathy in neoplastic patients.

Immunol 2010; 126: 527–534. 4 Currie GP, Jackson CM, Lee DK, et al. Determinants of airway hyperresponsiveness in mild asthma. Ann Allergy Asthma Immunol 2003; 90: 560–563. 5 Riemersma RA, Postma DS, Van der Molen T. Budesonide/ formoterol maintenance and reliever therapy in primary care asthma management: effects on bronchial hyperresponsiveness and asthma control. Prim Care Respir J 2012; 21: 50–56. 6 Aronsson D, Tufvesson E, Bjermer L. Comparison of central and peripheral airway involvement before and during methacholine, mannitol and eucapnic hyperventilation challenges in mild asthmatics. Clin Respir J 2011; 5: 10–18. 7 Douma WR, Kerstjens HAM, de Gooijer A, et al. Initial improvements in lung function and bronchial hyperresponsiveness are maintained during 5 years of treatment with inhaled beclomethasone dipropionate and terbutaline. Chest 2002; 121: 151–157. 8 Sont JK, Willems LN, Bel EH, et al. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 1999; 159: 1043–1051. 9 Barnes N, Price D, Colice G, et al. Asthma control with extrafineparticle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study. Clin Exp Allergy 2011; 41: 1521–1532. 10 Cohen J, Postma DS, Douma WR, et al. Particle size matters: diagnostics and treatment of small airways involvement in asthma. Eur Respir J 2011; 37: 532–540.